Leica Biosystems and Bio‑Techne announced the U.S. launch of RNAscope automation on Leica’s BOND‑PRIME staining platform, enabling fully automated RNAscope RNA in‑situ hybridization (ISH) with rapid turnaround for high‑throughput anatomic pathology labs. The integrated workflow promises RNA detection with spatial and morphological context in under eight hours. Leica emphasized improved lab efficiency and staining consistency, while Bio‑Techne highlighted expanded access to RNAscope assays. The launch addresses pathology demand for faster molecular spatial assays and may accelerate adoption of RNA ISH in clinical and translational diagnostics.